Latest Ratios: P/E Ratio -514.9x · EV/EBITDA N/A · ROE -3.3%. (1997–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.1B | $282M | $341M | $965M | $233M | $53M | $38M | $39M | $59M | $75M | $13M |
| Enterprise Value | $2.1B | $268M | $298M | $941M | $202M | $53M | $36M | $34M | $48M | $63M | $18M |
| P/E Ratio → | -514.92 | — | 10.28 | 66.04 | 24.65 | — | — | — | 130.00 | — | — |
| P/S Ratio | 35.71 | 4.79 | 5.15 | 14.85 | 4.58 | 3.18 | 1.69 | 1.86 | 2.00 | 3.94 | 0.91 |
| P/B Ratio | 16.12 | 2.30 | 3.05 | 12.76 | 4.56 | 4.61 | 2.69 | 2.54 | 3.07 | 4.44 | — |
| P/FCF | — | — | 338.52 | 111.54 | 213.14 | — | — | — | — | — | — |
| P/OCF | — | — | 194.13 | 96.36 | 154.34 | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 4.54 | 4.50 | 14.48 | 3.98 | 3.19 | 1.63 | 1.60 | 1.64 | 3.32 | 1.26 |
| EV / EBITDA | — | — | 26.04 | 68.06 | 24.95 | — | — | — | 36.41 | — | — |
| EV / EBIT | — | — | 23.91 | 64.37 | 21.20 | — | — | — | 56.79 | — | — |
| EV / FCF | — | — | 295.86 | 108.79 | 185.23 | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 40.6% | 40.6% | 49.1% | 50.4% | 46.6% | 36.3% | 37.6% | 36.1% | 41.9% | 35.9% | 35.5% |
| Operating Margin | -7.3% | -7.3% | 15.2% | 20.6% | 15.3% | -25.2% | -11.4% | -20.3% | 3.1% | -26.1% | -42.4% |
| Net Profit Margin | -6.6% | -6.6% | 50.1% | 22.4% | 18.6% | -12.2% | -12.6% | -24.9% | 1.8% | -29.9% | -46.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -3.3% | -3.3% | 35.4% | 23.0% | 30.3% | -15.9% | -19.0% | -30.1% | 2.9% | -70.4% | -354.6% |
| ROA | -2.8% | -2.8% | 29.3% | 18.1% | 22.5% | -9.6% | -13.4% | -20.0% | 1.7% | -27.6% | -54.5% |
| ROIC | -3.7% | -3.7% | 12.5% | 27.7% | 36.3% | -25.9% | -16.9% | -34.5% | 10.1% | -78.6% | -129.8% |
| ROCE | -3.4% | -3.4% | 10.1% | 20.1% | 24.4% | -28.5% | -15.7% | -24.0% | 4.3% | -34.7% | -89.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.09 | 0.09 | 0.06 | 0.08 | 0.02 | 0.42 | 0.28 | — | 0.32 | 0.36 | — |
| Debt / EBITDA | — | — | 0.54 | 0.46 | 0.12 | — | — | — | 4.59 | — | — |
| Net Debt / Equity | — | -0.12 | -0.38 | -0.31 | -0.60 | 0.02 | -0.11 | -0.35 | -0.56 | -0.70 | — |
| Net Debt / EBITDA | — | — | -3.76 | -1.72 | -3.76 | — | — | — | -8.06 | — | — |
| Debt / FCF | — | — | -42.66 | -2.75 | -27.91 | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | -46.91 | — | -19.67 | 2.14 | -7.30 | -10.20 |
Net cash position: cash ($25M) exceeds total debt ($11M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.68 | 5.68 | 9.31 | 5.46 | 5.45 | 2.12 | 4.57 | 3.63 | 2.64 | 3.73 | 1.87 |
| Quick Ratio | 2.99 | 2.99 | 5.75 | 3.99 | 4.08 | 1.14 | 2.50 | 1.99 | 1.83 | 2.89 | 0.37 |
| Cash Ratio | 1.61 | 1.61 | 4.68 | 2.94 | 2.86 | 0.51 | 1.41 | 0.98 | 1.51 | 2.26 | 0.20 |
| Asset Turnover | — | 0.40 | 0.52 | 0.66 | 0.82 | 0.77 | 1.08 | 0.99 | 0.95 | 0.61 | 1.44 |
| Inventory Turnover | 0.83 | 0.83 | 0.90 | 1.35 | 1.80 | 1.19 | 1.74 | 1.48 | 1.90 | 1.83 | 1.33 |
| Days Sales Outstanding | — | 110.12 | 55.10 | 93.24 | 92.34 | 114.38 | 60.86 | 84.23 | 35.27 | 77.45 | 13.14 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 9.7% | 1.5% | 4.1% | — | — | — | 0.8% | — | — |
| FCF Yield | — | — | 0.3% | 0.9% | 0.5% | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.3% | 0.5% | 0.2% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.3% | 0.5% | 0.2% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $30M | $30M | $29M | $28M | $23M | $23M | $22M | $23M | $16M | $13M |
EV market cyclicality
According to current market data, AEHR trades at a price-to-sales ratio of 48.97, which appears significantly elevated relative to historical norms and peer averages, suggesting that investors are pricing in a recovery that remains disconnected from the company's recent negative earnings and contracting revenue growth trajectory.
The extreme P/S multiple indicates that the market continues to assign a 'pure-play' growth premium to the stock, likely tied to long-term Silicon Carbide adoption. However, given the lack of positive P/E or FCF metrics, this valuation appears highly speculative and vulnerable to further downward revisions if the current EV-related demand plateau persists.
Based on reported financial statements, AEHR's ROIC has deteriorated to -2.9% in 2026Q3, a sharp reversal from the 10.4% peak observed in 2024Q2, which highlights the company's struggle to generate adequate returns on its invested capital during the current industry-wide downturn in semiconductor equipment spending.
The collapse in ROIC reflects both the compression of operating margins and the inefficient utilization of assets as revenue volumes decline. This trend suggests that the company's capital allocation strategy is currently failing to create value, necessitating a potential reassessment of R&D and inventory investment levels until demand stabilizes.
As reported in recent filings, the cash conversion cycle has ballooned to 610 days in 2026Q3, driven primarily by an inventory turnover period of 550 days, which indicates a significant buildup of unsold hardware that is currently tying up liquidity and hindering operational efficiency.
The dramatic increase in DIO suggests that the company is holding substantial inventory that may be difficult to liquidate in the current market environment. Investors should monitor whether this inventory represents future revenue potential or if it risks becoming obsolete as the industry shifts toward newer wafer-level testing standards.
Based on the latest quarterly balance sheet, AEHR maintains a current ratio of 10.97, providing a substantial liquidity cushion that, according to historical data, remains well above industry averages and offers the company significant runway to navigate the current period of negative operating cash flow.
While the company is currently burning cash, the high liquidity position mitigates immediate solvency risks and provides management with the flexibility to maintain R&D spending. This financial strength is a critical differentiator, allowing the firm to survive the 'SiC winter' without the immediate need for dilutive equity financing.
The price-to-sales ratio is frequently misapplied to AEHR, as it obscures the lumpy, project-based nature of system acceptances and fails to account for the high-margin, recurring revenue potential of the consumable WaferPak business model, which is the true driver of long-term value creation.
Analysts should instead focus on the 'WaferPak attach rate' and the ratio of consumables revenue to total revenue to gauge the underlying health of the business. Relying on P/S multiples in a cyclical equipment market often leads to over-optimism during peaks and excessive pessimism during troughs, failing to capture the structural shift toward recurring revenue.
Includes 30+ ratios · 29 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AEHR stock.
Aehr Test Systems's current P/E ratio is -514.9x. The historical average is 43.3x.
Aehr Test Systems's return on equity (ROE) is -3.3%. The historical average is -26.6%.
Based on historical data, Aehr Test Systems is trading at a P/E of -514.9x. Compare with industry peers and growth rates for a complete picture.
Aehr Test Systems has 40.6% gross margin and -7.3% operating margin.